Graphique du cours de l'action RDHL
RDHL Prix
Redhill Biopharma Ltd
$0.91
-0.98%
$0
À la fermeture : May 20, 16:00:00 GMT-4
$0.91
-0.97%
$0
Post-Marché: May 20, 17:37:40 GMT-4
Retour
Redhill Biopharma Ltd (RDHL) Prix
Statistiques clés
Clôture préc.
$0.9281
Prix d'ouverture
$0.91
Plage de la journée
$0.9001 - $0.9278
Plage de 52 semaines
$0.7101 - $3.3
Volume
58.5K
Volume moyen
339.7K
Rendement en dividend
--
BPA (TTM)
-0.00
Capitalisation boursière
$4.6M
Qu’est-ce que RDHL ?
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
Fonctionnalités
© 2026 Edgen fonctionné par
